LAROTRECTINIB

485 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAROTRECTINIB:

# Side effect Count
0 DIZZINESS 32
1 DRUG INEFFECTIVE 29
2 FATIGUE 28
3 PAIN 28
4 NAUSEA 21
5 OFF LABEL USE 21
6 DEATH 20
7 DISEASE PROGRESSION 19
8 NEUROPATHY PERIPHERAL 19
9 MYALGIA 14
See all common reactions for LAROTRECTINIB

LAROTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NTRK GENE FUSION OVEREXPRESSION 1 0.5000
1 PAROXYSMAL EXTREME PAIN DISORDER 1 0.2500
2 NASAL ASPIRATION 1 0.2500
3 FIBROSARCOMA METASTATIC 1 0.2000
4 MESOBLASTIC NEPHROMA 1 0.2000
5 UPPER AIRWAY NECROSIS 1 0.1000
6 SALIVARY GLAND CANCER RECURRENT 1 0.0833
7 ADENOCARCINOMA OF SALIVARY GLAND 2 0.0741
8 NEUROENDOCRINE CARCINOMA OF PROSTATE 1 0.0500
9 BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC 1 0.0357
See all enriched reactions for LAROTRECTINIB